Featured Article
Purdue Pharma to Stop Marketing Oxycontin to Doctors in the United States
Purdue Pharma to Stop Marketing Oxycontin to Doctors in the United States

After suffering years of massively negative public relations and countless lawsuits for its role in helping create the opioid epidemic, Purdue Pharma has announced it will cease marketing its painkiller OxyContin directly to doctors. The Stamford, CT, drugmaker says it will ...

Read More

Blog posts in February

  • In the Media: Kent Runyon on WFLA Discussing the Opioid Addiction Crisis

    Novus VP of Community Relations Kent Runyon discussed how the opioid addiction crisis is affecting people in Florida and across the United States on ...

    View More
  • FDA, FTC crack down on unapproved opioid addiction, withdrawal meds

    The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have sent joint warning letters to a dozen makers, marketers and ...

    View More
  • DEA Relaxes Buprenorphine Prescribing Rules to Boost Rural Opioid Addiction Treatment

    The U.S. Drug Enforcement Administration (DEA) has "deregulated" some restrictions on who is allowed to prescribe buprenorphine, to help expand the ...

    View More
  • Novus Set to Open Second Facility in West Palm Beach Later This Month

    Novus Detox held a ribbon cutting ceremony for its newest location in West Palm Beach on Thursday, February 1, set to officially open its doors later ...

    View More

Start Your New Path to Sobriety Today!

    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.